KYMR
Price
$44.12
Change
-$1.59 (-3.48%)
Updated
Jun 27 closing price
Capitalization
2.87B
34 days until earnings call
LYRA
Price
$9.11
Change
-$4.27 (-31.91%)
Updated
Jun 27 closing price
Capitalization
12.27M
45 days until earnings call
Interact to see
Advertisement

KYMR vs LYRA

Header iconKYMR vs LYRA Comparison
Open Charts KYMR vs LYRABanner chart's image
Kymera Therapeutics
Price$44.12
Change-$1.59 (-3.48%)
Volume$3.8M
Capitalization2.87B
Lyra Therapeutics
Price$9.11
Change-$4.27 (-31.91%)
Volume$747.49K
Capitalization12.27M
KYMR vs LYRA Comparison Chart in %
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. LYRA commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and LYRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (KYMR: $44.12 vs. LYRA: $9.26)
Brand notoriety: KYMR and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 402% vs. LYRA: 79%
Market capitalization -- KYMR: $2.87B vs. LYRA: $12.27M
KYMR [@Biotechnology] is valued at $2.87B. LYRA’s [@Biotechnology] market capitalization is $12.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileLYRA’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • LYRA’s FA Score: 0 green, 5 red.
According to our system of comparison, LYRA is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while LYRA’s TA Score has 5 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 4 bearish.
  • LYRA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both KYMR and LYRA are a good buy in the short-term.

Price Growth

KYMR (@Biotechnology) experienced а -3.82% price change this week, while LYRA (@Biotechnology) price change was -11.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 01, 2025.

LYRA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.87B) has a higher market cap than LYRA($12.3M). KYMR YTD gains are higher at: 9.669 vs. LYRA (-10.320). LYRA has higher annual earnings (EBITDA): -44.7M vs. KYMR (-232.67M). KYMR has more cash in the bank: 463M vs. LYRA (31.7M). LYRA has less debt than KYMR: LYRA (33.4M) vs KYMR (86.3M). KYMR has higher revenues than LYRA: KYMR (58.9M) vs LYRA (1.19M).
KYMRLYRAKYMR / LYRA
Capitalization2.87B12.3M23,358%
EBITDA-232.67M-44.7M520%
Gain YTD9.669-10.320-94%
P/E RatioN/AN/A-
Revenue58.9M1.19M4,970%
Total Cash463M31.7M1,461%
Total Debt86.3M33.4M258%
TECHNICAL ANALYSIS
Technical Analysis
KYMRLYRA
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 12 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAFFX81.910.67
+0.82%
American Funds Growth Fund of Amer F3
CLFFX20.570.14
+0.69%
Clifford Capital Partners Investor
VILSX37.290.17
+0.46%
Value Line Select Growth Institutional
SGDIX77.21N/A
N/A
Sprott Gold Equity Institutional
COSSX13.13N/A
N/A
Columbia Overseas Value Inst2

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been loosely correlated with EYPT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if LYRA jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
-30.83%
EYPT - LYRA
58%
Loosely correlated
-6.94%
VERA - LYRA
54%
Loosely correlated
-2.71%
KYMR - LYRA
50%
Loosely correlated
-3.48%
BPMC - LYRA
41%
Loosely correlated
-0.03%
CLNN - LYRA
39%
Loosely correlated
-3.57%
More